Three-year efficacy and safety of exenatide once weekly: A pooled analysis of three trials

Trautmann Michael E.; Van Gaal Luc; Han Jenny; Hardy Elise

首页> 外文期刊>Journal of diabetes and its complications >Three-year efficacy and safety of exenatide once weekly: A pooled analysis of three trials

【24h】

Three-year efficacy and safety of exenatide once weekly: A pooled analysis of three trials

机译：每周一次艾塞纳西亚的三年疗效和安全性：三项试验的汇总分析

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Aims: To evaluate the 3-year efficacy and safety of exenatide once weekly (QW) for type 2 diabetes (T2D) in a large clinical population.

机译：目的：在大型临床群体中，评估每周一次（QW）的3年效果和安全性（QW）。

著录项

来源
《Journal of diabetes and its complications》 |2017年第9期|共8页
作者
Trautmann Michael E.; Van Gaal Luc; Han Jenny; Hardy Elise;
展开▼
作者单位

Diabet Res Fueerbarg 16a D-22393 Hamburg Germany;

Antwerp Univ Hosp Antwerp Belgium;

Pharmapace San Diego CA USA;

AstraZeneca Gaithersburg MD USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类内分泌腺疾病及代谢病;
关键词
Exenatide; GLP-1 Glucagon-like peptide-1 receptor agonist; Type 2 diabetes; Long-term efficacy and safety Pooled analysis;

机译：eXenatide;GLP-1胰高血糖素样肽-1受体激动剂;2型糖尿病;长期疗效和安全汇总分析;

相似文献

外文文献
中文文献
专利

1. Three-year efficacy and safety of exenatide once weekly: A pooled analysis of three trials [J] . Trautmann Michael E., Van Gaal Luc, Han Jenny, Journal of diabetes and its complications . 2017,第9期

机译：每周一次艾塞纳西亚的三年疗效和安全性：三项试验的汇总分析
2. Efficacy and tolerability of exenatide twice daily and exenatide once weekly in Asian versus White patients with type 2 diabetes mellitus: A pooled analysis [J] . Sheu Wayne H. -H., Brunell Steven C., Blase Erich Diabetes research and clinical practice . 2016,第Null期

机译：艾塞司醛每日两次和艾塞那肽在亚洲与2型糖尿病患者中每周一次的疗效和含量持久性：汇总分析
3. Safety and Efficacy of Exenatide Once Weekly Plus Dapagliflozin Once Daily Versus Exenatide or Dapagliflozin Alone in Patients With Type 2 Diabetes Inadequately Controlled With Metformin Monotherapy: 52-Week Results of the DURATION-8 Randomized Controlled Trial [J] . Jabbour Serge A., Frias Juan P., Hardy Elise, Diabetes care . 2018,第10期

机译：Exenatide每周一次的安全性和疗效加上Dapagliflozin每日一度，并且单独服用exenatide或Dapagliflozin，患有2型糖尿病的患者与二甲双胍单疗法不充分控制：52周的持续时间-8随机对照试验
4. In Silico Trials for Drug Safety and Efficacy Assessment Using a Novel Human Purkinje Fibre Model [C] . C. Trovato, C. Dusserre, S. Billiald-Desquand, Computing in Cardiology . 2020

机译：使用新型人类的Purkinje纤维模型在Silico试验中的药物安全和功效评估
5. A 4-month randomized controlled clinical trial of adjuvant Exenatide or Pramlintide versus insulin alone in pediatric type 1 diabetes mellitus: Effect on glycemic control. [D] . Withycombe, Sarah Elizabeth. 2010

机译：儿科1型糖尿病患者中艾塞那肽或普兰林肽与单独使用胰岛素的4个月随机对照临床试验：对血糖控制的影响。
6. Safety and Efficacy of Exenatide Once Weekly Plus Dapagliflozin Once Daily Versus Exenatide or Dapagliflozin Alone in Patients With Type 2 Diabetes Inadequately Controlled With Metformin Monotherapy: 52-Week Results of the DURATION-8 Randomized Controlled Trial [O] . Serge A. Jabbour, Juan P. Frías, Elise Hardy, 2018

机译：二甲双胍单药治疗不能完全控制的2型糖尿病患者艾塞那肽每周一次加艾达那列或每日一次与艾塞那肽或达格列净相比的安全性和有效性：DURATION-8随机对照试验52周的结果
7. Efficacy and tolerability of exenatide twice daily and exenatide once weekly in Asian versus White patients with type 2 diabetes mellitus: A pooled analysis [O] . Sheu Wayne H.-H., Brunell Steven C., Blase Erich 2016

机译：亚裔患者与白人2型糖尿病患者每天两次艾塞那肽和每周一次艾塞那肽的疗效和耐受性：汇总分析

Three-year efficacy and safety of exenatide once weekly: A pooled analysis of three trials

摘要

著录项

相似文献

相关主题

期刊订阅